Blood Products Advisory Committee Meeting (BPAC)

On Wednesday, May 13, 2015 the Blood Products Advisory Committee (BPAC) voted about strategies for implementation of serological and nucleic acid testing for Babesia microti in blood donors. In addition, the Committee heard update presentations on the following topics: 1) FDA considerations for Hemoglobin S Testing in blood donors; and 2) FDA considerations for a revised blood donor deferral policy for men who have sex with men. Following the update presentations, the Committee heard presentations on the research programs of the Laboratory of Cellular Hematology, Division of Hematology Research and Review, Office of Blood Research and Review, Center for Biologics Evaluation and Research, FDA.